Data & Analytics

With its new non-control fund oversubscribed, New Mountain Capital is doubling down on its strategy of investing in resilient, acyclical industries.

Nearly 2,700 Kroger stores are now on Uber's apps, a massive play that reshapes the grocery delivery wars and directly challenges market leaders.

Merck's former R&D IT head Matt Studney joins TetraScience, a move highlighting biopharma's critical pivot from fragmented data to industrial-scale AI.

A new alliance in healthcare marketing merges pharmaceutical expertise with provider-side insights, leveraging AI and big data to fix a fragmented system.

With the appointment of finance veteran Deborah Ricci, Acentra Health signals a new phase of aggressive growth and strategic acquisitions in health tech.

Adial Pharmaceuticals files a key patent to protect its personalized Alcohol Use Disorder drug, AD04, until 2045, signaling a new era for addiction medicine.

A new partnership proves AI is only as good as its data, achieving a 10% lift in predictive models and a 19.5% drop in wasted marketing spend.

With a new Series Seed 2 round, data analytics firm Confianza is set to deepen its AI capabilities in insurance and expand into new industries.

With a sold-out show, Work Truck Week 2026 is a launchpad for new EVs, hydrogen tech, and smart systems, signaling a robust future for commercial vehicles.

With three new executive appointments, Armada signals an aggressive new strategy under CEO Chris O'Brien to unify its brand and accelerate growth.

Yuki's new 14-day free trial runs its full optimization platform on live Snowflake workloads, promising real savings instead of just simulations.

The acquisition of The Good Crisp Company by a Kroger-backed firm reveals a new playbook where consumer data and health trends dictate the future of snacking.

One of the nation's largest health systems is expanding its use of advanced AI and analytics to redefine clinical excellence and whole-person care.

As Lithuania's grid operator faces a new era of digital demands and renewable integration, a former telecom CTO is set to take the lead in a major strategic shift.

Adimab's stellar 2025 reveals its crucial role as the hidden tech platform driving drug discovery for giants like Lilly and Regeneron.

NYU Langone and tech firm Tempus are launching a new protocol using serial DNA sequencing and AI to create hyper-personalized cancer treatments.

Eason Technology is betting its future on Chinese real estate with a deal that could dilute shareholders by over 80%. But can it get past the NYSE?

A new partnership makes Eli Lilly's powerful AI models available to smaller firms via Revvity's platform, aiming to accelerate innovation with federated learning.

Radiant Ridge Energy's new 40MW project in Alberta bypasses the grid, converting natural gas directly into power for the booming AI and data industry.

With a new CEO from Illumina and Exact Sciences, Quanterix signals a strategic shift from tech development to aggressive market and clinical expansion.